Rik Coin

Rik Coin

Created using Figma
The RIKNKT Blockchain Platform (RBP) is a network that seamlessly connects services across national borders between cancer patients and people who want to prevent cancers around the world and a healthcare provider that provides the innovative cancer treatment method "RIKNKT", and also service necessary for medical treatment. In addition to comprehensively combining other cancer treatment technologies to create a comprehensive medical package, we will broadly incorporate and develop advanced medicine that is not approved for insurance, such as anti-aging medical technology.
  • Market
    Pair
    Price
    Volume 24H
    24H (price)
    24H (volume)
  • HitBTC
    RIK/ETH 5 one year ago
    $ 0.0029
    $ 0.5152
    -
    -
  • HitBTC
    RIK/USD 5 one year ago
    $ 0.0031
    -
    -
    -
  • HitBTC
    RIK/BTC 5 one year ago
    $ 0.0027
    $ 4.12
    -
    -
Phase 4
Jul 13, 2018
Aug 10, 2018
100% completed
Raised funds - no Data
past
Phase 3
Jun 15, 2018
Jul 13, 2018
100% completed
Raised funds - no Data
past
Phase 2
May 18, 2018
Jun 15, 2018
100% completed
Raised funds - no Data
past
Phase 1
Apr 23, 2018
May 18, 2018
100% completed
Raised funds - no Data
past
Additional Details
Categories
Cryptocurrency

About Rik Coin

We are a bio venture company from RIKEN, Japan (RIKEN), a major global think tank. We developed a novel cancer treatment method "RIKNKT" with minimal invasion (few overall events disturb the homeostasis in vivo due to external factors) and almost no side effect, that uses cells with intense antitumor effect researched by RIKEN and many other medical institutions. Since June 2008, we have begun offering it at private medical institutions under legal procedures in the regenerative medicine new law in Japan.

As a result of medical provision, about 80% of patients were able to obtain partial remission (A state in which the cancer contracts and the symptoms are improved), complete remission(A condition in which symptoms of cancer disappear and the numerical value of examination also shows normal), and stop progress, regardless of site or stage, which verifies that it has a high response rate (the size of cancer shrinks).

Based on these results, we will spread this therapy in full scale expecting that as many patients as possible can receive treatment from now on while cancer patients are increasing. At the same time, we will further advance our technology development. Additionally, we will continue our drug discovery business to acquire drug approval.

 

  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.